COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,861 Articles (22,568 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 2104: Articles 21031-21040  | Next

Population-based prevalence surveys during the COVID-19 pandemic: a systematic review
Franceschi, V. B., Santos, A. S., Glaeser, A. B., Paiz, J. C., Caldana, G. D., Lessa, C. L. M., Mayer, A. d. M., Kuchle, J. G., Zen, P. R. G., Vigo, A., Winck, A. T., Rotta, L. N., Thompson, C. E.
10.1101/2020.10.20.20216259 — Posted: 2020-10-22
Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
Gharamti, A. A., Mei, F., Jankousky, K. C., Huang, J., Hyson, P., Chastain, D. B., Fan, J., Osae, S., Zhang, W. W., Montoya, J. G., Erlandson, K. M., Scherger, S. J., Franco-Paredes, C., Henao-Martinez, A. F., Shapiro, L.
10.1101/2020.10.20.20216309 — Posted: 2020-10-22
The incubation period of COVID-19: A scoping review and meta-analysis to aid modelling and planning
Banka, P., Comiskey, C. M.
10.1101/2020.10.20.20216143 — Posted: 2020-10-22
Challenges Faced by Dialysis Unit Staff during COVID -19 times-A Qualitative Study
KUMAR, P. R., Dongre, A. R.
10.1101/2020.10.20.20215715 — Posted: 2020-10-21 Discussion: Onsite
Clinical characteristics of 4490 COVID-19 patients in Africa: A meta-analysis
Olumade, T. J., Uzairue, L. I.
10.1101/2020.10.20.20215905 — Posted: 2020-10-21
Restriction of SARS-CoV-2 Replication by Targeting Programmed -1 Ribosomal Frameshifting In Vitro
Sun, Y., Abriola, L., Surovtseva, Y. V., Lindenbach, B. D., Guo, J. U.
10.1101/2020.10.21.349225 — Posted: 2020-10-21
Structural basis for the inhibition of the SARS-CoV-2 RNA-dependent RNA polymerase by favipiravir-RTP
Naydenova, K., Muir, K. W., Wu, L.-F., Zhang, Z., Coscia, F., Peet, M. J., Castro-Hartmann, P., Qian, P., Sader, K., Dent, K., Kimanius, D., Sutherland, J. D., Lowe, J., Barford, D., Russo, C. J.
10.1101/2020.10.21.347690 — Posted: 2020-10-21
Preclinical study of DNA vaccines targeting SARS-CoV-2
Hayashi, H., Sun, J., Yanagida, Y., Otera, T., Kubota-Kotetsu, R., Shioda, T., Ono, C., Matsuura, Y., Arase, H., Yoshida, S., Nakamaru, R., Ide, R., Tenma, A., Kawabata, S., Ehara, T., Sakaguchi, M., Tomioka, H., Shimamura, M., Okamoto, S., Amaishi, Y., Chono, H., Mineno, J., Komatsuno, T., Saito, Y., Rakugi, H., Morishita, R., Nakagami, H.
10.1101/2020.10.21.347799 — Posted: 2020-10-21
Validation of expert system enhanced deep learning algorithm for automated screening for COVID-Pneumonia on chest X-rays
Gidde, P. S., Prasad, S. S., Singh, A. P., Batheja, N., Prakash, S., Singh, P., Saboo, A., Thakar, R., Gupta, S., Saurav, S., Raghunandan, M. V., Singh, A., Sardana, V., Mahajan, H., Kalyanpur, A., Mandal, A. S., Mahajan, V., Agrawal, A., Agrawal, A., Venugopal, V. K., Singh, S., Dash, D.
10.1101/2020.10.20.20213793 — Posted: 2020-10-21
Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory.
Cramer, A., Goodman, N., Cross, T., Gant, V. A., Dziadzio, M.
10.1101/2020.10.20.20215970 — Posted: 2020-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).